Symposium:
170. Update on Transplantation in HIV-Infected Recipients
Friday, October 9, 2015: 2:00 PM-3:30 PM
Room: 6--DE

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • review the selection criteria, outcomes, and management considerations for HIV-infected patients undergoing transplantation
  • discuss the potential impact that hematopoietic stem cell transplantation has on HIV-1 reservoirs and persistence
  • explain critical antiretroviral and immunosuppressive drug-drug interactions

Target Audience: Researchers, Scientists, Pharmacists, Members-in-training, Investigators, Infectious diseases physicians, HIV specialists, HIV clinicians, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Investigative ID, HIV-STD-TB, Adult ID

Moderators:  Kimberly Hanson, MD, MHS, University of Utah School of Medicine and Aruna Subramanian, MD, FIDSA, Stanford University School of Medicine

Presentations:
2:00 PM
1257
HIV and Solid Organ Transplantation
Aruna Subramanian, MD, FIDSA

2:30 PM
1258
HIV and Hematopoietic Stem Cell Transplantation
John Zaia, MD, FIDSA

3:00 PM
1259
Critical Antiretroviral and Immunosuppressive Regimen Drug Interactions
Jennifer Cocohoba, PharmD

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-176-L02-P

Disclosures:

K. Hanson, None

A. Subramanian, None

See more of: Symposium
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.